Geneva Partners, LLC Zoetis Inc. Transaction History

Geneva Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$144.0 - $169.39 $1.77 Million - $2.08 Million	-12,275 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$157.07 - $174.35 $2.24 Million - $2.49 Million	-14,285 Reduced 53.78%	12,275 $2.03 Million
Q3 2020 Oct 28, 2020	SELL	$137.1 - $165.37 $193,311 - $233,171	-1,410 Reduced 5.04%	26,560 $4.39 Million
Q2 2020 Jul 20, 2020	BUY	$111.92 - $142.53 $118,635 - $151,081	1,060 Added 3.94%	27,970 $3.83 Million
Q1 2020 Apr 27, 2020	SELL	$92.66 - $144.94 $171,421 - $268,139	-1,850 Reduced 6.43%	26,910 $3.17 Million
Q4 2019 Feb 04, 2020	SELL	$116.25 - $133.25 $70,447 - $80,749	-606 Reduced 2.06%	28,760 $3.81 Million
Q3 2019 Nov 06, 2019	SELL	$112.57 - $128.43 $821,648 - $937,410	-7,299 Reduced 19.91%	29,366 $3.66 Million
Q2 2019 Jul 31, 2019	BUY	$97.98 - $114.28 $320,884 - $374,267	3,275 Added 9.81%	36,665 $4.16 Million
Q1 2019 May 10, 2019	BUY	$81.56 - $100.67 $1.36 Million - $1.68 Million	16,720 Added 100.3%	33,390 $3.36 Million
Q4 2018 Jan 30, 2019	SELL	$79.28 - $95.27 $60,649 - $72,881	-765 Reduced 4.39%	16,670 $1.43 Million
Q3 2018 Oct 23, 2018	BUY	$83.5 - $93.23 $419,170 - $468,014	5,020 Added 40.43%	17,435 $1.6 Million
Q2 2018 Aug 09, 2018	BUY	$79.9 - $89.2 $991,958 - $1.11 Million	12,415 New	12,415 $1.06 Million

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Partners, LLC with notifications on news.